49,513 Shares in Waters Co. (NYSE:WAT) Bought by Edgestream Partners L.P.

Edgestream Partners L.P. acquired a new position in shares of Waters Co. (NYSE:WAT) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 49,513 shares of the medical instruments supplier’s stock, valued at approximately $10,657,000. Waters comprises about 1.2% of Edgestream Partners L.P.’s holdings, making the stock its 22nd biggest holding. Edgestream Partners L.P. owned approximately 0.07% of Waters as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently modified their holdings of the business. JPMorgan Chase & Co. lifted its holdings in Waters by 20.7% in the second quarter. JPMorgan Chase & Co. now owns 179,470 shares of the medical instruments supplier’s stock valued at $38,312,000 after buying an additional 30,822 shares during the period. Livforsakringsbolaget Skandia Omsesidigt lifted its holdings in Waters by 46.1% in the second quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 951 shares of the medical instruments supplier’s stock valued at $205,000 after buying an additional 300 shares during the period. First Trust Advisors LP lifted its holdings in Waters by 1,148.3% in the second quarter. First Trust Advisors LP now owns 86,505 shares of the medical instruments supplier’s stock valued at $18,619,000 after buying an additional 79,575 shares during the period. WINTON GROUP Ltd lifted its holdings in Waters by 3.0% in the second quarter. WINTON GROUP Ltd now owns 121,999 shares of the medical instruments supplier’s stock valued at $26,259,000 after buying an additional 3,586 shares during the period. Finally, SFE Investment Counsel lifted its holdings in Waters by 32.8% in the second quarter. SFE Investment Counsel now owns 4,689 shares of the medical instruments supplier’s stock valued at $1,009,000 after buying an additional 1,158 shares during the period. 95.08% of the stock is currently owned by hedge funds and other institutional investors.

WAT has been the topic of several analyst reports. Cleveland Research lowered shares of Waters from a “neutral” rating to an “underperform” rating in a report on Wednesday, June 12th. ValuEngine downgraded shares of Waters from a “buy” rating to a “hold” rating in a research report on Thursday, August 1st. Bank of America downgraded shares of Waters from a “neutral” rating to an “underperform” rating in a research report on Tuesday, July 16th. Wolfe Research initiated coverage on shares of Waters in a research report on Thursday, May 30th. They set an “underperform” rating for the company. Finally, Zacks Investment Research raised shares of Waters from a “sell” rating to a “hold” rating and set a $217.00 target price for the company in a research report on Wednesday, May 22nd. Five investment analysts have rated the stock with a sell rating, eight have issued a hold rating and one has given a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average price target of $210.54.

NYSE WAT traded up $0.58 during trading on Friday, hitting $233.36. 3,147 shares of the company’s stock traded hands, compared to its average volume of 455,780. The stock has a market capitalization of $14.90 billion, a price-to-earnings ratio of 28.20, a PEG ratio of 2.50 and a beta of 1.08. Waters Co. has a 12-month low of $167.93 and a 12-month high of $255.21. The company has a debt-to-equity ratio of 2.00, a quick ratio of 2.07 and a current ratio of 2.65. The business has a 50 day moving average of $211.39 and a 200-day moving average of $221.34.

Waters (NYSE:WAT) last announced its quarterly earnings results on Tuesday, July 30th. The medical instruments supplier reported $2.14 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.11 by $0.03. Waters had a net margin of 24.09% and a return on equity of 50.64%. The firm had revenue of $599.20 million for the quarter, compared to the consensus estimate of $601.46 million. During the same period in the prior year, the firm posted $1.95 earnings per share. The company’s revenue for the quarter was up .5% on a year-over-year basis. On average, analysts expect that Waters Co. will post 9.01 EPS for the current year.

About Waters

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Further Reading: How to find the components of the quick ratio

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.